Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cell Secretome in Lupus Patients
NCT05921058Phase 2Completed
- Sponsor
- Universitas Sebelas Maret
- Start
- Aug 2022
- Primary completion
- Dec 2022
- Modality
- Lipid-based Nanoparticles, Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised trial in systemic lupus erythematosus (SLE) comparing Messenchymal stem cell secretome with Placebo (2 arms). Primary endpoint: Change of Lupus Disease Activity at 1 month. Started Aug 2022; status: completed.
02
Drugs
mesenchymal stem cell secretome
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT05921058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05921058.